Designed for senior retail executives operating up to 250 stores, the NACDS Regional Chain Conference offers unique programming and educational opportunities with fellow peers and trading partners.
“NACDS aims to provide the most compelling and timely programming in all of its meetings, and the Regional Chain Conference offers programming and opportunities like no other industry event for small and medium-sized retailers and suppliers,” said NACDS President and CEO Steven C. Anderson, IOM, CAE. “With insights from top industry leaders, interactive programming on key industry issues and high-caliber programming to assist in day-to-day and long-term business planning, the NACDS Regional Chain Conference is a must-attend event for industry leaders in 2013.”
Attendees will have an opportunity to hear from industry leaders including David Cippel, president of Klingensmith’s Drug Stores, Inc. and chairman of the 2013 NACDS Regional Chain Conference; Greg Wasson, president and chief executive officer of Walgreen Co. and NACDS chairman of the Board; and Steven C. Anderson, IOM, CAE, president and chief executive officer of NACDS.
General session presentations at the NACDS Regional Chain Conference include: The OTC Economic Divide - Past, Present & Future by Jeff Gregori, vice president, consumer & shopper analytics, Nielsen,; Pharmaceutical Trends, Issues and Forecasts by Douglas M. Long, vice president, industry relations, IMS Health Incorporated; Pharmacy Care Opportunities in Patient-Centered Care Models by Justin Heiser, PharmD, vice president, pharmacy operations, Thrifty White Pharmacy and Justin May, PharmD, director of pharmacy, Red Cross Pharmacies; Tuning into Mom: Understanding America’s Most Powerful Consumer by Michal Clements, marketing strategist, Tuningintomom.com; Labor & Employment: What Trends You Need to Know by Deborah Kelly, partner and deputy general counsel, Dickstein Shapiro LLP.
The enhanced structure of the Chain & Associate Member Interactive Idea Exchange sessions is designed to foster in-depth discussion on a variety of industry issues. Pre-determined topics will be outlined for each of these sessions for attendees to fully maximize these interactive and educational sessions. These interactive sessions include: Medication Synchronization-Strategies for Improving Patient and Healthcare Relationships by David Holdford, professor and vice chair for graduate studies, Virginia Commonwealth University School of Pharmacy; Emphasizing Quality: Directions for Medicare and Pharmacy Services by Vikki Oates, director of division of clinical and operational performance, Centers for Medicare & Medicaid Services (CMS); Part II: Pharmaceutical Trends, Issues and Forecasts, by Doug Long, vice president, industry relations, IMS Health Incorporated; Part II: Labor Law and Social Media, Deborah Kelly, partner and deputy general counsel, Dickstein Shapiro LLP; Part II: Patient-Centered Care Models, by Justin Heiser, PharmD, vice president, pharmacy operations, Thrifty White Pharmacy, and Justin May, PharmD, director of pharmacy, Red Cross Pharmacies; Using Star Ratings to Drive Business, Vikki Oates, director of division of clinical and operational performance, CMS.
In addition, other high-caliber education sessions during the conference include Developing Specialty Pharmacy by Gary M. Cohen, BSPharm, RPh, chief executive officer, National Association of Specialty Pharmacy and Michael A. Nameth, RPh, MBA, chief executive officer, Town Total Health; and NACDS on your Side: How to Effectively Leverage Your Company in Government Affairs, Public Policy and Communications, by Carol Kelly, senior vice president, government affairs and public policy, NACDS and Chris Krese, senior vice president, marketing, communications and media relations, NACDS.
“In its 80th year, NACDS continues to strive for excellence in all of our programs and meetings, and we look forward to continuing that mission as we embark on the next 80 years,” said Anderson.
Visit the NACDS Regional Chain Conference website for more information.
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs